NZ296562A - Recombinant peptides and secretory mehods for their preparation - Google Patents
Recombinant peptides and secretory mehods for their preparationInfo
- Publication number
- NZ296562A NZ296562A NZ296562A NZ29656295A NZ296562A NZ 296562 A NZ296562 A NZ 296562A NZ 296562 A NZ296562 A NZ 296562A NZ 29656295 A NZ29656295 A NZ 29656295A NZ 296562 A NZ296562 A NZ 296562A
- Authority
- NZ
- New Zealand
- Prior art keywords
- peptide
- sequence
- mehods
- secretory
- preparation
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 10
- 230000003248 secreting effect Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
A method for secreting a biologically active recombinant peptide as an analogue of a natural peptide having at least one hydrophobic region, by culturing cells transformed by a nucleic acid construct comprising elements for the expression and secretion of the peptide by the cell, and a sequence coding for a peptide with an amino acid sequence that differs from the natural peptide sequence in that it has at least one modification in a non-transmembrane hydrophobic region of the peptide; and by recovering the peptide and/or cells carrying the recombinant peptide. The resulting recombinant peptide, a corresponding DNA sequence, and a bacterium containing same, are also disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9413307A FR2726576B1 (en) | 1994-11-07 | 1994-11-07 | PRODUCTION OF HYDROPHOBIC PEPTIDE-LIKE PEPTIDES, RECOMBINANT PEPTIDE, CORRESPONDING DNA SEQUENCE |
PCT/FR1995/001464 WO1996014409A1 (en) | 1994-11-07 | 1995-11-07 | Production of recombinant peptides as natural hydrophobic peptide analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ296562A true NZ296562A (en) | 1999-11-29 |
Family
ID=9468565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ296562A NZ296562A (en) | 1994-11-07 | 1995-11-07 | Recombinant peptides and secretory mehods for their preparation |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0791059A1 (en) |
JP (1) | JPH10508479A (en) |
AU (1) | AU704594B2 (en) |
CA (1) | CA2204511A1 (en) |
FR (1) | FR2726576B1 (en) |
NZ (1) | NZ296562A (en) |
WO (1) | WO1996014409A1 (en) |
ZA (1) | ZA959417B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5789653A (en) * | 1995-01-10 | 1998-08-04 | University Of Edinburgh | Secretory gene trap |
GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
AUPO026596A0 (en) * | 1996-06-05 | 1996-06-27 | Biomolecular Research Institute Limited | Viral peptide |
FR2766192B1 (en) * | 1997-07-17 | 2001-07-13 | Pf Medicament | EPITOPES OF RSV AND ANTIBODIES COMPRISING SAME, USEFUL IN DIAGNOSIS AND THERAPY |
EP1276756A4 (en) | 2000-04-12 | 2004-06-09 | Human Genome Sciences Inc | Albumin fusion proteins |
FR2819810B1 (en) * | 2001-01-23 | 2004-05-28 | Pf Medicament | NON-GLYCOSYL PEPTIDES DERIVED FROM RSV PROTEIN G AND THEIR USE IN A VACCINE |
US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
ES2545090T3 (en) | 2001-12-21 | 2015-09-08 | Human Genome Sciences, Inc. | Albumin and GCSF fusion proteins |
WO2015120541A1 (en) * | 2014-02-14 | 2015-08-20 | Symvivo Corporation | Nucleic acid vectors and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01501357A (en) * | 1986-01-14 | 1989-05-18 | ユニバ−シテイ・オブ・ノ−ス・カロライナ | Vaccines for human respiratory viruses |
US4734362A (en) * | 1986-02-03 | 1988-03-29 | Cambridge Bioscience Corporation | Process for purifying recombinant proteins, and products thereof |
US4925784A (en) * | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
EP0249477A3 (en) * | 1986-06-12 | 1988-01-20 | Immunex Corporation | Functional recombinant analog polypeptides devoid of hydrophobic amino acids |
US5223254A (en) * | 1987-09-29 | 1993-06-29 | Praxis Biologics, Inc. | Respiratory syncytial virus: vaccines |
ES2176174T3 (en) * | 1988-12-22 | 2002-12-01 | Genentech Inc | PROCEDURE FOR PREPARATION OF WATER SOLUBLE POLYPEPTIDES. |
-
1994
- 1994-11-07 FR FR9413307A patent/FR2726576B1/en not_active Expired - Fee Related
-
1995
- 1995-11-07 EP EP95939336A patent/EP0791059A1/en not_active Withdrawn
- 1995-11-07 CA CA002204511A patent/CA2204511A1/en not_active Abandoned
- 1995-11-07 JP JP8515108A patent/JPH10508479A/en active Pending
- 1995-11-07 NZ NZ296562A patent/NZ296562A/en unknown
- 1995-11-07 ZA ZA959417A patent/ZA959417B/en unknown
- 1995-11-07 WO PCT/FR1995/001464 patent/WO1996014409A1/en not_active Application Discontinuation
- 1995-11-07 AU AU41200/96A patent/AU704594B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
ZA959417B (en) | 1996-06-11 |
FR2726576B1 (en) | 1997-01-31 |
FR2726576A1 (en) | 1996-05-10 |
EP0791059A1 (en) | 1997-08-27 |
WO1996014409A1 (en) | 1996-05-17 |
AU704594B2 (en) | 1999-04-29 |
AU4120096A (en) | 1996-05-31 |
JPH10508479A (en) | 1998-08-25 |
CA2204511A1 (en) | 1996-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997026321A3 (en) | Recombinant expression of proteins from secretory cell lines | |
HK1055317A1 (en) | Expression of biologically active polypeptides in duckweed | |
MX9902661A (en) | High level expression of proteins | |
IL86480A0 (en) | Recombinant dna coding for human proapolipoprotein a-i,expression vectors containing it and cells transformed by said expression vector | |
HUP0001650A2 (en) | Improved expression vectors | |
IL206293A0 (en) | Genetically engineered duckweed | |
IE820069L (en) | Recombinant dna encoding a polypeptide | |
HK1004150A1 (en) | Calcium free subtilisin mutants. | |
AU7599500A (en) | Novel gl50 molecules and uses therefor | |
HK1007435A1 (en) | Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms | |
EP0088622A3 (en) | Animal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and expression vehicles containing such sequences and cells transformed thereby | |
ES8703520A1 (en) | Particles having immunogen HBs antigen properties and bearing an antigenic site, foreign to the epitopes of HBs antigen, vectors and animal cells for the production of those particles of mixed vaccines. | |
AU7869487A (en) | Expression of biologically active factor XIII | |
NZ296562A (en) | Recombinant peptides and secretory mehods for their preparation | |
AU7093601A (en) | Nucleic acid molecules encoding plant cell cycle proteins and uses therefor | |
CA2260365A1 (en) | Differentiation-suppressive polypeptide | |
WO2002000722A3 (en) | Human calcium channels (48000; 52920) and uses thereof | |
GB8616219D0 (en) | Monoclonal antibodies | |
IL126221A0 (en) | Scf analog compositions and methods | |
IL111372A0 (en) | Dna sequences for ammonium transporter, plasmids, bacteria, yeasts, plant cells and plants containing the transporter | |
AU5776799A (en) | Modified hcv peptide vaccines | |
EP2281892A3 (en) | Methods for producing polypeptides in respiratory-deficient Trichoderma cells | |
GB9901499D0 (en) | Biological control | |
ATE139568T1 (en) | ACHROMOBACTER PROTEASE I GENE AND GENE PRODUCT | |
AU2789000A (en) | Sequences for improving the efficiency of secretion of non-secreted proteins from mammalian and insect cells |